Company News in the Life Science Industry

»

Reset 

CRN Decries Harm to Public Interest and Calls Out Significant Legal Deficiencies in Amarin Pharma Complaint against Omega-3 Companies

WASHINGTON, Sept. 14, 2017 /PRNewswire-USNewswire/ -- The Council for Responsible Nutrition (CRN), the leading trade association for the dietary supplement industry, today strongly urged the United States International Trade Commission (ITC) to reject a complaint filed by Amarin Pharma... Read more ››

By: PR Newswire Association LLC. - 15 Sep 2017

Raising the Bar for Nursing Education - Laerdal Medical Introduces Nursing Anne Simulator

WAPPINGERS FALLS, N.Y., Sept. 14, 2017 /PRNewswire/ -- The role and responsibilities within nursing have undergone profound changes within the last twenty-five years, resulting in a stronger emphasis on patient-centered care, diagnosis and assessment, and an improved transition from the classroom... Read more ››

By: PR Newswire Association LLC. - 14 Sep 2017

Champions Oncology Reports Record Quarterly Revenue of $5 Million

HACKENSACK, N.J., Sept. 14, 2017 /PRNewswire/ -- Champions Oncology, Inc. (Nasdaq: CSBR), engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, today announced its financial results for the first quarter ended July 31,... Read more ››

By: PR Newswire Association LLC. - 14 Sep 2017
Related companies:  Champions Oncology, Inc.

Mirati Therapeutics Presents Positive Preliminary Data From On-Going Clinical Trials Of Sitravatinib In Non-Small Cell Lung Cancer

SAN DIEGO, Sept. 14, 2017 /PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical stage targeted oncology biotechnology company, announced that positive preliminary data from two ongoing clinical trials of sitravatinib in non-small cell lung cancer (NSCLC) will be presented Friday,... Read more ››

By: PR Newswire Association LLC. - 14 Sep 2017
Related companies:  Mirati Therapeutics Inc.

Pear Therapeutics Obtains FDA Clearance of the First Prescription Digital Therapeutic to Treat Disease

BOSTON and SAN FRANCISCO, Sept.14, 2017 /PRNewswire/ -- Pear Therapeutics, the leader in a new era of prescription digital therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has granted Pear's De Novo request, allowing the company to market reSET® for the treatment... Read more ››

By: PR Newswire Association LLC. - 14 Sep 2017
Related companies:  Pear Therapeutics, Inc.

Bayer Receives FDA Approval for Aliqopa(TM) (copanlisib) 60 mg vial for Injection in Adults with Relapsed Follicular Lymphoma after Two Prior Systemic Therapies

WHIPPANY, N.J., Sept. 14, 2017 /PRNewswire/ -- Bayer announced today that the U.S. Food and Drug Administration (FDA) has approved Aliqopa((TM) )(copanlisib) for the treatment of adult patients with relapsed FL who have received at least two prior systemic therapies.(1) Accelerated approval was... Read more ››

By: PR Newswire Association LLC. - 14 Sep 2017
Related companies:  Bayer HealthCare, LLC Animal Health Division | Bayer CropScience LP | Bayer Healthcare LLC

Advocates Slam House for Passing Spending Bill with Rider to Repeal D.C. Medical Aid-in-Dying Law

WASHINGTON, Sept. 14, 2017 /PRNewswire-USNewswire/ -- Supporters of D.C.'s Death with Dignity Act criticized the U.S. House of Representatives today for passing the 2018 D.C. Appropriations bill with a... Read more ››

By: PR Newswire Association LLC. - 14 Sep 2017

Sierra Oncology to Host KOL Call with Dr. Thomas Helleday presenting "DNA Damage Response (DDR) Targets Beyond PARP"

VANCOUVER, Sept. 14, 2017 /CNW/ - Sierra Oncology, Inc. (SRRA), a clinical stage drug development company focused on advancing next generation DNA Damage Response (DDR) therapeutics for the treatment of patients with cancer, today announced that it will host a Key Opinion Leader call on the topic... Read more ››

By: PR Newswire Association LLC. - 14 Sep 2017
Related companies:  Sierra Oncology, Inc.

Precision ADM Receives ISO 13485 Medical Device Manufacturing Certification

WINNIPEG, Sept. 14, 2017 /PRNewswire/ - Precision ADM Inc. is pleased to announce that it is the first Canadian metal Additive and Subtractive manufacturing services company to receive ISO 13485:2016 Quality Management System certification. This industry standard represents the comprehensive... Read more ››

By: PR Newswire Association LLC. - 14 Sep 2017

Increase of Nexstim Plc's share capital with subscriptions based on stock options 2013A

Read more ››
By: Nasdaq / GlobenewsWire - 14 Sep 2017

Nestlé acquires majority interest in Blue Bottle Coffee

Read more ››
By: Nasdaq / GlobenewsWire - 14 Sep 2017

Guerbet Announces CE Mark for Vectorio®, An Innovative Medical Device for cTACE Procedures

Read more ››
By: Nasdaq / GlobenewsWire - 14 Sep 2017
Related companies:  Global Blood Therapeutics Inc.

AB Science announces that CHMP adopted a negative opinion for masitinib marketing authorization in indolent systemic mastocytosis after reassessment

Read more ››
By: Nasdaq / GlobenewsWire - 14 Sep 2017
Related companies:  AB Science SA

Independent Data Monitoring Committee Recommends Discontinuation of Bavarian Nordic's Phase 3 Study of PROSTVAC in Metastatic Prostate Cancer

Read more ››
By: Nasdaq / GlobenewsWire - 14 Sep 2017
Related companies:  Bavarian Nordic A/S | Bavarian Nordic GmbH

Microbiotix and the AMR Centre Announce Co-Development Agreement Targeting Drug Resistant P. aeruginosa in Critically Ill Pneumonia Patients

WORCESTER, Mass. and ALDERLEY PARK, England , Sept. 14, 2017 /PRNewswire/ -- Microbiotix, Inc., a clinical stage biotech company focused on the discovery and development of novel drugs that target serious infectious diseases, and the AMR Centre, a joint private-public initiative to support/accelerate... Read more ››

By: PR Newswire Association LLC. - 14 Sep 2017
Related companies:  Microbiotix, Inc. | The AMR Centre UK

Teva Partnering Deals and Alliances 2010 to 2017

LONDON, Sept. 14, 2017 /PRNewswire/ -- The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering activity of one of the world's leading life sciences companies.


Download the full report: Read more ››

By: PR Newswire Association LLC. - 14 Sep 2017

Investment and Strategic Partnership: Daimler Trucks teams up with innovation leader for electric charging StoreDot Ltd.

STUTTGART, Germany and TEL-AVIV, Israel, Sept. 14, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 14 Sep 2017

Mylan Expands Women's Healthcare Portfolio with Launch of Generic Minastrin® 24 FE Tablets

HERTFORDSHIRE, England and PITTSBURGH, Sept. 14, 2017 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL), today announced the U.S. launch of Norethindrone Acetate and Ethinyl Estradiol Tablets USP, and Ferrous Fumarate Tablets, 1 mg/20 mcg, which is indicated for use by women to prevent pregnancy... Read more ››

By: PR Newswire Association LLC. - 14 Sep 2017
Related companies:  Mylan (UK)

3SBio Partnering Deals and Alliances 2010 to 2017

LONDON, Sept. 14, 2017 /PRNewswire/ -- The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering activity of one of the world's leading life sciences companies.

Download the full report: Read more ››

By: PR Newswire Association LLC. - 14 Sep 2017

Global Biomarkers Technologies, Companies and Markets Research Report 2017 - Projections to 2026

DUBLIN, September 14, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 14 Sep 2017
Related companies:  Ascendiant Capital Markets LLC | RBC Capital Markets | KeyBanc Capital Markets
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19 20  21  22  23  24  25 »

Explore our database of over 40,000 companies